Learn · Peptides

BPC-157, explained

A 15-amino-acid synthetic peptide with decades of laboratory and animal research behind it — and very little human trial data. What has been studied, and where the evidence stops.

BPC-157 is one of the most talked-about peptides online, and one of the least understood. It is a synthetic peptide that has been studied for decades — but almost entirely in laboratory and animal experiments, not in large human trials. This guide explains what BPC-157 is, what researchers have actually studied, where the evidence stops, and what its regulatory status means.

What BPC-157 is

BPC-157 is a synthetic peptide made of 15 amino acids. The letters stand for “body protection compound,” a name given by the research group that first described it in the 1990s. Its sequence is taken from a portion of a protein found in human gastric juice — which is why much of the early research focused on the digestive tract.

It is not a hormone, and the 15-amino-acid fragment itself is made in a laboratory rather than harvested from the body. Researchers have used it as a tool for studying how tissues respond to injury.

What researchers have studied

Most published work on BPC-157 comes from cell-culture and animal studies, and a large share of it comes from a single research group. In those models, investigators have examined the peptide in the context of the digestive tract, of tendon, ligament and muscle injury, and of wound healing.

Proposed mechanisms from that work include effects on the formation of new blood vessels, on nitric oxide signaling, and on the activity of fibroblasts — the cells that build connective tissue. These are observations about how the peptide behaves in experimental systems. They are hypotheses about mechanism, not demonstrations of a benefit in people.

Where the evidence stops

Human research on BPC-157 is limited to a small number of early-stage studies. There are no large, controlled clinical trials establishing that it is safe or effective for any condition. Results in animals frequently fail to carry over to humans, and that gap is the single most important thing to understand about this peptide.

Long-term safety has not been characterized. Regulators have also raised questions specific to peptides of this kind, including the potential for immune reactions and for impurities introduced during manufacturing — one reason the source and documentation of any product matter.

What a prescribed protocol looks like

The form, the amount, the schedule and the duration of any protocol are decisions made by the prescribing provider for the individual patient. Nothing in this article should be read as a dosing recommendation. If a source online offers you BPC-157 without a licensed provider and a real evaluation involved, treat that as a warning sign, not a shortcut.

FDA status and compounding: what to know

The regulatory picture here deserves precision. BPC-157 is not an FDA-approved medication: no product containing it has been approved by the FDA for any use. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety or efficacy.

In July 2026, an FDA advisory committee reviewed whether BPC-157 should be added to the list of substances that pharmacies may use in compounding. That review concerns what licensed pharmacies may prepare on a valid prescription. It is not an FDA approval, and it does not establish that BPC-157 is safe or effective for any use.

BPC-157 is not yet available through Peptivik. If and when it is offered, it will be by prescription only, after an evaluation by a licensed provider, and prepared for individual patients by state-licensed US compounding pharmacies — a different regulatory lane than FDA premarket review, and one you should expect any honest platform to disclose plainly.

If you compete in a tested sport

BPC-157 appears on the World Anti-Doping Agency's Prohibited List, which applies to athletes in sports that follow the WADA code. If you are subject to drug testing, check your sport's current rules before considering it.

Questions worth asking a provider

  • What the human evidence does and does not show for the reason you are considering it.
  • What is known, and what is not known, about side effects and long-term safety.
  • How the product is sourced and tested, and what documentation exists for the lot you would receive.
  • What they would want to evaluate first, and what would lead them to advise against it.

The bottom line

BPC-157 is a synthetic peptide with a long record of laboratory and animal research and very little human trial data. It is not FDA-approved for any use. Whether it is appropriate for you is a decision that belongs with a licensed provider who can weigh that limited evidence against your health history.

This content is educational and not a substitute for advice from your provider.

← All guides